Royalty Pharma (RPRX) Announces Clinical Trial Update
Royalty Pharma (RPRX) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: opportunity, trillion
Diseases/Conditions: royalty funding in life sciences, New York City today
📋 Royalty Pharma plc (RPRX) - Clinical Trial Update
Filing Date: 2022-05-17
Accepted: 2022-05-17 07:37:14
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
Structured Data: